Related Experiment Videos
[Secondary tumoral pleurisy]
Jeanne-Marie Bréchot1, Thierry Molina, Pascale Jacoulet
1Service de pneumologie, Hôtel-Dieu, 1, Place du Parvis Notre-Dame, 75181 Paris. jeanne-marie.brechot@htd.ap-hop-paris.fr
Presse Medicale (Paris, France : 1983)
|May 3, 2002
Summary
Diagnosing tumoral pleurisy involves comparing pleural samples to known primary cancers or performing pleuroscopy when the primary cancer is unknown. Treatment combines local pleural sympysis with systemic therapies.
Area of Science:
- Oncology
- Pulmonology
- Pathology
Context:
- Secondary tumoral pleurisy complicates neoplastic disease evolution.
- Diagnosis is straightforward when the primary cancer is known, utilizing cytology and biopsy for comparison.
- Pleurisy can be the initial manifestation of an undiagnosed neoplastic disease, posing diagnostic challenges.
Purpose:
- To outline diagnostic strategies for tumoral pleurisy.
- To emphasize the importance of anatomopathological confirmation.
- To describe therapeutic approaches for malignant pleural effusion.
Summary:
- When the primary cancer is known, diagnosis of secondary tumoral pleurisy relies on cytological analysis and biopsy, comparing pleural findings with the primary tumor.
- When the primary cancer is unknown, pleurisy may be the presenting sign, necessitating focused investigations and prioritizing pleural diagnosis via pleuroscopy.
- Treatment involves local management, such as pleural sympysis (talc pleurodesis), and systemic therapies tailored to the underlying neoplasm.
Impact:
- Facilitates accurate diagnosis of malignant pleural effusion.
- Guides appropriate diagnostic and therapeutic interventions in cancer patients with pleurisy.
- Improves patient management by integrating local and systemic treatment strategies.